Global Blood Therapeutics Inc (NASDAQ:GBT)

Delayed Data
As of Oct 21
 -3.06 / -5.22%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 17 analysts offering 12-month price forecasts for Global Blood Therapeutics Inc have a median target of 115.00, with a high estimate of 152.00 and a low estimate of 64.00. The median estimate represents a +106.91% increase from the last price of 55.58.

Analyst Recommendations

The current consensus among 18 polled investment analysts is to Buy stock in Global Blood Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 14.64%
Growthannually 25.42%


Growthquarterly 39.62%
Growthannually 6,758.76%
Key to the earnings and sales forecast charts.